AXIOGENES Share Price

Stocks

End-of-day quote Xetra Other stock markets
- ^EUR	-

14/15/14	Axiogenes : s : Signs Sublicensing Agreement for Cellular Assay Patents with GE Healthcare.	BU
04/12/04	AXIOGENES : Axiogenesis Earns U.S. Patent with In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy	BU
10/11/10	AXIOGENES : At Last, a Cardiomyopathy Disease Model: Axiogenesis Has Been Granted a Far-Reaching Patent in Europe	BU

16/15/16

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-1.03%	+5.24%	+2.94%	+9.41%	5.03TCr
REVOLUTION MEDICINES, INC.	+0.25%	+1.70%	+419.39%	+621.71%	4.04TCr
IQVIA HOLDINGS INC.	+1.10%	+7.77%	+28.18%	-3.96%	3.44TCr
BEONE MEDICINES AG	-0.16%	+8.12%	+27.85%	+62.55%	3.44TCr
CELLTRION, INC.	+1.31%	-0.56%	+5.12%	+33.90%	2.63TCr
ASCENDIS PHARMA A/S	-0.35%	+0.09%	-	-	1.66TCr
MEDPACE HOLDINGS, INC.	-3.33%	+3.15%	+71.30%	+131.94%	1.61TCr
EUROFINS SCIENTIFIC SE	+0.32%	+0.53%	+14.33%	+21.47%	1.37TCr
IONIS PHARMACEUTICALS, INC.	+3.79%	+8.88%	+106.63%	+106.63%	1.37TCr
Average	+0.18%	+4.45%	+84.47%	+122.96%	2.73TCr
Weighted average by Cap.	+0.05%	+5.02%	+95.76%	+141.20%

Employees

Sector